| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $818.4M | +2.2% | +8.4% |
| Cost of Revenue | $170.5M | +3.1% | +8.9% |
| Gross Profit | $647.8M | +2.0% | +8.3% |
| R&D Expense | $167.6M | -1.2% | +10.9% |
| SG&A Expense | $98.3M | +3.6% | +0.8% |
| Operating Income | $85.4M | +30.9% | +44.6% |
| Pre-tax Income | $95.5M | +24.9% | +33.5% |
| Income Tax | $11.8M | -12.5% | +29.0% |
| Net Income | $83.7M | +33.0% | +34.1% |
| EPS (Basic) | $0.41 | +32.3% | +32.3% |
| EPS (Diluted) | $0.40 | +33.3% | +33.3% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $583.3M | -2.8% | -4.5% |
| Accounts Receivable | $355.0M | -0.6% | +18.2% |
| Current Assets | $1.31B | -0.9% | -1.9% |
| Total Assets | $3.98B | +0.8% | +5.6% |
| Current Liabilities | $1.78B | +0.4% | +11.6% |
| Total Liabilities | $2.00B |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $787.8M | — | — |
| Capital Expenditures | $79.4M | — | — |
| Investing Cash Flow | -$93.1M | — | — |
| Financing Cash Flow | -$767.3M | — | — |
| Free Cash Flow | $708.4M | — | — |
| +12.3% |
| Stockholders' Equity | $1.98B | -0.3% | -0.4% |